{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T01:10:54.798767+00:00","published_at":"2026-10-16T13:52:50.363049+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1o8krnk52775q","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:alistair-milnes","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:090eed7b97f234fc008f655d836ce8b52df141398aaab01617b8cfd47144b2a0"],"summary":"Alistair Milnes executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wravbl1jr2lrf","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:jennifer-perry-pharm-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:52870b1aa86c267d87ffda8b4e84586289033ebb7076294cf39de8f0a27c4203"],"summary":"Jennifer Perry, Pharm.D. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sif8x011ae1la","event_type":"CEO_CHANGED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:kevin-lee-ph-d-mba","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:b548657a6b4ec7fd93a6a88fc7acd2a89dea446bf73123cb4d83a46d0bf1d6fc"],"summary":"Kevin Lee, Ph.D., MBA executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:10osoelu0mnyh","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:michael-hannay-d-sc","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:ba7c6fd9451349f759e548cbe9845f3bd4dc4bfef96d14822606c8fa8e7a192c"],"summary":"Michael Hannay, D.Sc. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1s5784p4n0y73","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:michael-skynner-ph-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:04712cf3785b2e368aac7e187eaf4094589147700c1ac5b7ac119af56c2663a4"],"summary":"Michael Skynner, Ph.D. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1584qhhknwl5","event_type":"CFO_CHANGED","effective_at":"2026-04-22","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:tommy-thompson","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:20"],"evidence_ids":["alpha:projection-evidence:document:d2761c6a788505dcce0997912fc0d20d0561facd691490b662fef76d89421f35"],"summary":"Travis Thompson executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hq57bz1wux0y1","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:alessandro-riva-m-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Alessandro Riva, M.D. seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13qew461rsccty","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:charles-swanton-m-d-ph-d-frs-fmedsci-frcp","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1m19u3q1h0euqs","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:herv-hoppenot","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Hervé Hoppenot seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dbs0o31ciitub","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:roger-dansey-m-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Roger Dansey, M.D. seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1t2f8aa177b6tg","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:committee:bicycle-therapeutics-plc:audit-compensation","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Audit; Compensation committee of BICYCLE THERAPEUTICS PLC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wpkv3vfmec43","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:herv-hoppenot","alpha:committee:bicycle-therapeutics-plc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Hervé Hoppenot member of Audit; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fkj8vk1p0vmv6","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:felix-j-baker-ph-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Felix J. Baker, Ph.D. seat on BICYCLE THERAPEUTICS PLC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:r06ic21ev7kmg","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:stephen-sands-mba","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Stephen Sands, MBA seat on BICYCLE THERAPEUTICS PLC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kmx4fo6axuvo","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:committee:bicycle-therapeutics-plc:audit-chair-compensation","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Audit · Chair; Compensation committee of BICYCLE THERAPEUTICS PLC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3z2af91pxipu7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:stephen-sands-mba","alpha:committee:bicycle-therapeutics-plc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Stephen Sands, MBA member of Audit · Chair; Compensation, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lw6lcxspetcd","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:jose-carlos-gutierrez-ramos-ph-d","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Jose-Carlos Gutierrez-Ramos, Ph.D. seat on BICYCLE THERAPEUTICS PLC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:k35fxjls8vfv","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:kevin-lee-ph-d-mba","alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c"],"caused_claim_ids":["alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca"],"summary":"Kevin Lee, Ph.D., MBA seat on BICYCLE THERAPEUTICS PLC, effective 2015-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:5","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alessandro-riva-m-d","object_label":"Alessandro Riva, M.D.","object_source_name_forms":[],"value":"Alessandro Riva, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alessandro-riva-m-d","name":"Alessandro Riva, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:6","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-swanton-m-d-ph-d-frs-fmedsci-frcp","object_label":"Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP","object_source_name_forms":[],"value":"Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-swanton-m-d-ph-d-frs-fmedsci-frcp","name":"Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:7","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:felix-j-baker-ph-d","object_label":"Felix J. Baker, Ph.D.","object_source_name_forms":[],"value":"Felix J. Baker, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:felix-j-baker-ph-d","name":"Felix J. Baker, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:8","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:herv-hoppenot","object_label":"Hervé Hoppenot","object_source_name_forms":[],"value":"Hervé Hoppenot: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:herv-hoppenot","name":"Hervé Hoppenot"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:10","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jose-carlos-gutierrez-ramos-ph-d","object_label":"Jose-Carlos Gutierrez-Ramos, Ph.D.","object_source_name_forms":[],"value":"Jose-Carlos Gutierrez-Ramos, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jose-carlos-gutierrez-ramos-ph-d","name":"Jose-Carlos Gutierrez-Ramos, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:11","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kevin-lee-ph-d-mba","object_label":"Kevin Lee, Ph.D., MBA","object_source_name_forms":[],"value":"Kevin Lee, Ph.D., MBA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kevin-lee-ph-d-mba","name":"Kevin Lee, Ph.D., MBA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:12","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-dansey-m-d","object_label":"Roger Dansey, M.D.","object_source_name_forms":[],"value":"Roger Dansey, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:roger-dansey-m-d","name":"Roger Dansey, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:14","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephen-sands-mba","object_label":"Stephen Sands, MBA","object_source_name_forms":[],"value":"Stephen Sands, MBA: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stephen-sands-mba","name":"Stephen Sands, MBA"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:15","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alistair-milnes","object_label":"Alistair Milnes","object_source_name_forms":[],"value":"Alistair Milnes: Chief Corporate Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alistair-milnes","name":"Alistair Milnes"},"title":"Chief Corporate Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:090eed7b97f234fc008f655d836ce8b52df141398aaab01617b8cfd47144b2a0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:38.551357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:16","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jennifer-perry-pharm-d","object_label":"Jennifer Perry, Pharm.D.","object_source_name_forms":[],"value":"Jennifer Perry, Pharm.D.: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jennifer-perry-pharm-d","name":"Jennifer Perry, Pharm.D."},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:52870b1aa86c267d87ffda8b4e84586289033ebb7076294cf39de8f0a27c4203","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:37.672338+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:17","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kevin-lee-ph-d-mba","object_label":"Kevin Lee, Ph.D., MBA","object_source_name_forms":[],"value":"Kevin Lee, Ph.D., MBA: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kevin-lee-ph-d-mba","name":"Kevin Lee, Ph.D., MBA"},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b548657a6b4ec7fd93a6a88fc7acd2a89dea446bf73123cb4d83a46d0bf1d6fc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:36.40033+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:18","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-hannay-d-sc","object_label":"Michael Hannay, D.Sc.","object_source_name_forms":[],"value":"Michael Hannay, D.Sc.: Chief Product and Supply Chain Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-hannay-d-sc","name":"Michael Hannay, D.Sc."},"title":"Chief Product and Supply Chain Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:ba7c6fd9451349f759e548cbe9845f3bd4dc4bfef96d14822606c8fa8e7a192c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:37.234315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:19","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-skynner-ph-d","object_label":"Michael Skynner, Ph.D.","object_source_name_forms":[],"value":"Michael Skynner, Ph.D.: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-skynner-ph-d","name":"Michael Skynner, Ph.D."},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:04712cf3785b2e368aac7e187eaf4094589147700c1ac5b7ac119af56c2663a4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:38.109842+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:20","subject_id":"alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:tommy-thompson","object_label":"Travis Thompson","object_source_name_forms":[],"value":"Travis Thompson: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:tommy-thompson","name":"Travis Thompson"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:d2761c6a788505dcce0997912fc0d20d0561facd691490b662fef76d89421f35","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:36.786439+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:b91a7e46c15412a03bc349019cbd261bdb3581ef437af9c1e7e6ec0a3724e4ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:14:01.563+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:090eed7b97f234fc008f655d836ce8b52df141398aaab01617b8cfd47144b2a0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:38.551357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:52870b1aa86c267d87ffda8b4e84586289033ebb7076294cf39de8f0a27c4203","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:37.672338+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b548657a6b4ec7fd93a6a88fc7acd2a89dea446bf73123cb4d83a46d0bf1d6fc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:36.40033+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ba7c6fd9451349f759e548cbe9845f3bd4dc4bfef96d14822606c8fa8e7a192c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:37.234315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:04712cf3785b2e368aac7e187eaf4094589147700c1ac5b7ac119af56c2663a4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:38.109842+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d2761c6a788505dcce0997912fc0d20d0561facd691490b662fef76d89421f35","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BCYC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-15T23:26:36.786439+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.842,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.913,"cross_source_agreement":0.75,"temporal_completeness":0.609},"diagnostics":{"published_claims":30,"factual_claims":30,"claims_with_linked_evidence":30,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":23,"temporal_claims_with_valid_from":14,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:50.363049+00:00","observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":"2026-10-16T13:52:50.363049+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":30,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/bicycle-therapeutics-plc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/bicycle-therapeutics-plc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}